Your browser doesn't support javascript.
loading
Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children.
Vecchione, Andrea; Di Fonte, Roberta; Gerosa, Jolanda; Jofra, Tatiana; Cicalese, Maria Pia; Napoleone, Vincenzo; Ippolito, Elio; Galvani, Giuseppe; Ragogna, Francesca; Stabilini, Angela; Bianconi, Eleonora; Grogan, Pauline; Bonura, Clara; Bonfanti, Riccardo; Frontino, Giulio; Nano, Rita; Melzi, Raffaela; De Pellegrin, Maurizio; Laurenzi, Andrea; Meschi, Franco; Barera, Graziano; Rigamonti, Andrea; Indirli, Rita; Bosi, Emanuele; Piemonti, Lorenzo; Aiuti, Alessandro; Battaglia, Manuela; Fousteri, Georgia.
Afiliação
  • Vecchione A; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Di Fonte R; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy; IRCCS Istituto tumori "G.Paolo II" of Bari, Bari, Italy.
  • Gerosa J; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Jofra T; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Cicalese MP; San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Napoleone V; Biodigita, Florence, Italy.
  • Ippolito E; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Galvani G; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ragogna F; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Stabilini A; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bianconi E; Department of Internal Medicine, IRCCS San Raffaele Hospital, Milan, Italy; TrialNet Clinical Center, IRCCS San Raffaele Hospital, Milan, Italy.
  • Grogan P; TrialNet Clinical Center, IRCCS San Raffaele Hospital, Milan, Italy; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Bonura C; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Bonfanti R; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Frontino G; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Nano R; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Melzi R; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • De Pellegrin M; Department of Pediatric Orthopedics, IRCCS San Raffaele Hospital, Milan, Italy.
  • Laurenzi A; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Internal Medicine, IRCCS San Raffaele Hospital, Milan, Italy.
  • Meschi F; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Barera G; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Rigamonti A; Department of Pediatrics and Neonatology, IRCCS San Raffaele Hospital, Milan, Italy.
  • Indirli R; Department of Internal Medicine, IRCCS San Raffaele Hospital, Milan, Italy.
  • Bosi E; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Department of Internal Medicine, IRCCS San Raffaele Hospital, Milan, Italy; TrialNet Clinical Center, IRCCS San Raffaele Hospital, Milan, Italy.
  • Piemonti L; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy.
  • Aiuti A; San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy; Pediatric Immunohematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Battaglia M; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy; TrialNet Clinical Center, IRCCS San Raffaele Hospital, Milan, Italy.
  • Fousteri G; Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: fousteri.georgia@hsr.it.
Clin Immunol ; 211: 108319, 2020 02.
Article em En | MEDLINE | ID: mdl-31794865
ABSTRACT
Autoantibodies (AAbs) are a hallmark of Type 1 diabetes (T1D). Alterations in the frequency and phenotype of follicular helper (Tfh) T cells have been previously documented in patients with type 1 diabetes (T1D), but the contribution of follicular regulatory T (Treg) cells, which are responsible for suppressing AAb development, is less clear. Here, we investigated the frequency and activation status of follicular (CXCR5+) and conventional (CXCR5-) Treg cells in the blood of children with new-onset T1D, and children with risk for developing T1D (AAb-positive) and compared them to AAb-negative controls. Blood follicular and conventional Treg cells were higher in frequency in children with new onset T1D, but expressed reduced amounts of PD-1 as compared to AAb-negative children. Interestingly, the proportion of circulating FOXP3+ Tregs expressing PD-1 was also reduced in AAb-positive at-risk children as compared to AAb-negative controls, suggesting its potential use as a biomarker of disease progression. Follicular Treg cells were reduced in frequency in the spleens of prediabetic NOD mice as they became older and turned diabetic. Interestingly, PD-1 expression declined also on circulating follicular and conventional Treg cells in prediabetic NOD mice as they aged. Together, these findings show that the frequency of circulating follicular and conventional Treg cells and their levels of PD-1 change with disease progression in children at-risk for developing T1D and in NOD mice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de saúde: 2_muertes_prevenibles / 6_diabetes / 6_endocrine_disorders / 7_non_communicable_diseases / 7_nutrition Assunto principal: Linfócitos T Reguladores / Diabetes Mellitus Tipo 1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles / 7_ODS3_muertes_prevenibles_nacidos_ninos Problema de saúde: 2_muertes_prevenibles / 6_diabetes / 6_endocrine_disorders / 7_non_communicable_diseases / 7_nutrition Assunto principal: Linfócitos T Reguladores / Diabetes Mellitus Tipo 1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Animals / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Clin Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália
...